POPULARITY
Dr. Matthew Barrett and Dr. Michael S. Okun discuss the caution and deliberation needed in understanding Parkinson disease biomarkers. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820441
Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers. Read the related viewpoint piece in JAMA Neurology. Disclosures can be found at Neurology.org.
In this conversation with Dr. Vanessa Milanese, we cover the importance of anatomy in neurosurgery and explore her intriguing work in both fields – and how they cross-informed one another. Vanessa is a functional neurosurgeon at A Beneficencia Portuguesa Hospital in São Paulo, Brazil and holds an adjunct assistant professorship of neurosurgery at Mayo Clinic in Jacksonville, Florida. We talk about her stellar work in combining her neurosurgical activity with anatomical work – which involves dissections of the white matter of postmortem brains using the Klingler's method. We will talk about the rare community of neurosurgeons involved in similar activities, world-wide and the big influence Dr. Al Rhoton had on the field and on Vanessa's career. We thoroughly enjoyed this conversation and learned a lot – and we hope you will enjoy it as much as we did! Thank you so much for tuning in! References we talked about in the episode: Holanda, Vanessa M., Michael S. Okun, Erik H. Middlebrooks, Abuzer Gungor, Margaret E. Barry, John Forder, and Kelly D. Foote. 2020. “Postmortem Dissections of Common Targets for Lesion and Deep Brain Stimulation Surgeries.” Neurosurgery 86 (6): 860–72. https://journals.lww.com/neurosurgery/abstract/2020/06000/postmortem_dissections_of_common_targets_for.14.aspx Holanda, Vanessa Milanesi, Maria Cristina Chavantes, Xingjia Wu, and Juanita J. Anders. 2017. “The Mechanistic Basis for Photobiomodulation Therapy of Neuropathic Pain by near Infrared Laser Light.” Lasers in Surgery and Medicine 49 (5): 516–24. https://www.thieme-connect.de/products/ejournals/pdf/10.1002/lsm.22628.pdf Middlebrooks, Erik H., Ibrahim S. Tuna, Leonardo Almeida, Sanjeet S. Grewal, Joshua Wong, Michael G. Heckman, Elizabeth R. Lesser, et al. 2018. “Structural Connectivity-Based Segmentation of the Thalamus and Prediction of Tremor Improvement Following Thalamic Deep Brain Stimulation of the Ventral Intermediate Nucleus.” NeuroImage. Clinical 20 (October): 1266–73. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308387/ Middlebrooks, Erik H., Sanjeet S. Grewal, and Vanessa M. Holanda. 2019. “Complexities of Connectivity-Based DBS Targeting: Rebirth of the Debate on Thalamic and Subthalamic Treatment of Tremor.” NeuroImage. Clinical. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543122/ Ferreira, Tancredo Alcântara, Jr, Erik H. Middlebrooks, Wen Hung Tzu, Mateus Reghin Neto, and Vanessa Milanesi Holanda. 2020. “Postmortem Dissections of the Papez Circuit and Nonmotor Targets for Functional Neurosurgery.” World Neurosurgery 144 (December): e866–75. https://www.sciencedirect.com/science/article/abs/pii/S1878875020320969?via%3Dihub Additional Resources we talked about: Mayo Functional Neuro Course 2024: https://ce.mayo.edu/functionalneuro2024 Scaniverse app for 3D brain reconstruction: https://apps.apple.com/br/app/scaniverse-3d-scanner/id1541433223?l=en-GB Rhoton's book: https://shop.lww.com/Rhoton-Cranial-Anatomy-and-Surgical-Approaches/p/9781975226879 Stênio Holanda Filho Q&A book: https://www.dilivros.com.br/livro-neuroanatomia-pratica-e-ilustrada-questoes--e-respostas--3d-9788580531527,h18213.html Deep Brain Stimulation: A case-based approach https://academic.oup.com/book/29505
In this episode, we explore Parkinson's disease (PD), which is the second most common neurodegenerative disorder of aging after Alzheimer's disease, and the most common movement disorder. It affects approximately 1 million people in the United States, and it is estimated that 60,000 new cases are diagnosed each year. Worldwide more than 10 million people suffer from PD. We described the disease in a patient story, discussed its epidemiology, causal pathways including genetics, signs and symptoms, medical and invasive treatments, prevention and future trends in research. For more reading, here are some references: Bloem, Bastiaan R., Michael S. Okun, and Christine Klein. "Parkinson's disease." The Lancet 397.10291 (2021): 2284-2303. Ascherio, Alberto, and Michael A. Schwarzschild. "The epidemiology of Parkinson's disease: risk factors and prevention." The Lancet Neurology 15.12 (2016): 1257-1272. Chen, Honglei, et al. "Consumption of dairy products and risk of Parkinson's disease." American journal of epidemiology, 165.9 (2007): 998-1006. Warnecke, Tobias, et al. "Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management." npj Parkinson's Disease 8.1 (2022): 31. Follow us: To participate in the weekly NEURO Science Club and join the discussions about the latest on brain health, join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com
January 17 marks the 81st anniversary of the birth of one of the greatest Parkinson's advocates of all time, Muhammad Ali. In this episode, we learn more about the champ's journey from his eldest daughter Maryum “May May” Ali – the stigma her father dealt with after his diagnosis, when she first noticed changes in her dad, struggles with speaking and medication, and how he improved his quality of life. In addition to exploring Ali's Parkinson's legacy, Dr. Michael S. Okun, the head of neurology for the University of Florida Norman Fixel Institute for Neurological Diseases, sheds light on Ali's PD diagnosis. Okun and two other neurologists, the final three neurologists to treat Ali over the course of many years, published an article in October 2022 to clear up misinformation about his diagnosis. Ali was a young onset Parkinson's disease patient that responds to Levodopa which is different if his Parkinson's onset due to his boxing career and punches to the head. EMAIL Larry and Rebecca: ParkinsonsPod@curiouscast.ca Have questions, comments, or a story idea? We would love you to click here and leave a message https://www.speakpipe.com/WhenLifeGivesYouParkinsons Follow us, Larry & Rebecca Gifford Twitter: @ParkinsonsPod Facebook: Facebook.com/ParkinsonsPod Instagram: @parkinsonspod KEY LINKS Maryum “May May” Ali - website RESOURCES Muhammad Ali and Young-Onset Idiopathic Parkinson Disease—The Missing Evidence Thanks to Curiouscast Dila Velazquez – Story Producer Our Presenting Partner is Parkinson Canada. Diagnosed with Parkinson's? You are not alone. Contact presenting partner Parkinson Canada http://www.parkinson.ca/, call the toll free hotline 1-800-565-3000 or on Twitter you can message @ParkinsonCanada. Thanks also to our content and promotional partners The Michael J. Fox Foundation's Parkinson's IQ + You Events PD Avengers – We are building a global alliance to end Parkinson's. Join us. World Parkinson Congress 2023 – It's time to make your congress and hotel registrations. Details on the website. Spotlight YOPD – One of the only Parkinson's organizations dedicated to raising awareness for Young Onset Parkinson's disease and funds for the Cure Parkinson's Trust.
In this episode of When Life Gives You Parkinson’s, three of the authors of the book Ending Parkinson’s Disease explain how Parkinson’s is preventable. WLGYP’s host Larry Gifford interviewed Bas Bloem MD, PhD, Ray Dorsey MD, and Michael S. Okun MD for a Parkinson Canada webinar. Larry, his wife Rebecca and co-host Niki Reitmayer listen, learn and react to the author’s frank discussion of Parkinson’s disease, why they believe it is preventable, who is at risk, how COVID-19 maybe triggering the onset of PD, and why more and more experts believe it to be a global pandemic. Thank you for listening. Add your voice to the show and leave a message for us here; https://www.speakpipe.com/WhenLifeGivesYouParkinsons Follow us, Larry & Rebecca Gifford Twitter: @ParkinsonsPod Facebook: Facebook.com/ParkinsonsPod Instagram: @parkinsonspod Follow Co-host and Producer Niki Reitmeyer Twitter: @Niki_Reitmayer Thank you to the following people featured in this episode… Bas Bloem MD, Phd, Ray Dorsey, MD and Michael S. Okun, MD – details on their book are available at www.endingpd.ord Diagnosed with Parkinson’s? You are not alone. Contact presenting partner Parkinson Canada http://www.parkinson.ca/, call toll free hotline 1-800-565-3000, on Twitter @ParkinsonCanada Thanks also to our content and promotional partners Parkinson’s IQ + You– A free, series of Parkinson’s events from the Michael J. Fox Foundation Spotlight YOPD – The only Parkinson’s organization dedicated to raising awareness for Young Onset Parkinson’s disease and funds for the Cure Parkinson’s Trust. PD Avengers - We want to help end Parkinson’s disease. Join us. World Parkinson Congress 2022 –Make plans to join us for #WPC2022 in Barcelona, Spain. See omnystudio.com/listener for privacy information.
More than 6 million people worldwide have Parkinson disease. Even though it is classically associated with tremors, the disease has many manifestations and is very treatable for most patients. Michael S. Okun, MD, from the Department of Neurology at the University of Florida, Gainesville, discusses the pathophysiology, clinical presentation, diagnosis, and treatment of Parkinson disease. Related: Choosing a Parkinson Disease Treatment
Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old. In Ending Parkinson's Disease: A Prescription for Action (Public Affairs, 2020), Ray Dorsey MD, Todd Sherer PhD, Michael S. Okun MD, and Bastiaan R. Bloem MD PhD provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old. In Ending Parkinson's Disease: A Prescription for Action (Public Affairs, 2020), Ray Dorsey MD, Todd Sherer PhD, Michael S. Okun MD, and Bastiaan R. Bloem MD PhD provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old. In Ending Parkinson's Disease: A Prescription for Action (Public Affairs, 2020), Ray Dorsey MD, Todd Sherer PhD, Michael S. Okun MD, and Bastiaan R. Bloem MD PhD provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine
Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson's continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old. In Ending Parkinson's Disease: A Prescription for Action (Public Affairs, 2020), Ray Dorsey MD, Todd Sherer PhD, Michael S. Okun MD, and Bastiaan R. Bloem MD PhD provide a plan to help prevent Parkinson's, improve care and treatment, and end the silence associated with this devastating disease. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology
More than 6 million people worldwide have Parkinson disease. Even though it is classically associated with tremors, the disease has many manifestations and is very treatable for most patients. Michael S. Okun, MD, from the Department of Neurology at the University of Florida, Gainesville, discusses the pathophysiology, clinical presentation, diagnosis, and treatment of Parkinson disease. Related article: Parkinson Disease AMA Manual of Style
Around one million Americans today live with Parkinson's Disease, a debilitating chronic movement disorder that eventually robs those who suffer with it of most motor function. The cause of the disease is still unknown and there is no known cure, but Lisa Cox of Spartanburg is going above and beyond to raise awareness of Parkinson's while fostering collaboration among researchers and the community of people who live with the disease. She, along with three other Parkinson's patients living in states around the Southeast, has organized the first ever , a four-day series of events covering everything from the role the arts play in medicine to a Q & A session with internationally renowned neurologist, Dr. Michael S. Okun. The symposium also features events highlighting the lives and accomplishments of those living with Parkinson's including the screening of , a documentary about Rich Clifford, a NASA astronaut who was one of the first to conduct a space walk while docked to an orbiting space station, something he accomplished despite suffering with Parkinson's.